• Most Popular
  • Most Shared

Investment Outlook Summit

Photo

Reuters talks to portfolio managers and strategists to find what's on the horizon. Learn how to position your portfolio in the year ahead.   Full Coverage 

Roche sees substantial synergies in Genentech deal

BASEL, Switzerland
Mon Jul 21, 2008 1:55am EDT

BASEL, Switzerland (Reuters) - Swiss drugmaker Roche Holding AG said on Monday it sees substantial synergies from the Genentech deal and that there would be no need for a capital increase.

The group said it was confident of putting together a consortium of banks to finance the $43.7 billion buy of all outstanding shares in its U.S. partner and that it sees no problems financing the deal.

(Reporting by Sam Cage)


More from Reuters

Photo

Accused 9/11 plotters may face NY "Guantanamo"

NEW YORK (Reuters) - If the men accused of plotting the September 11 attacks wonder what conditions they might face when they are moved to New York from Guantanamo Bay for trial, they can expect solitary confinement, 23-hour-a-day lockdowns, constant video surveillance and almost no visitors.

» More Top News
Traders in the oil options pit work at the New York Mercantile Exchange, September 9, 2008. REUTERS/Chip East
Analysis:

"More assumptions, more risk"

New oil and gas reserve rules were supposed to improve transparency, but the unforeseen consequences of the regulations could add a layer of uncertainty for investors.  Full Article 

regulatory news
The sun sets over the Mackenzie Delta near Inuvik, Northwest Territories November 11, 2009. Credit: REUTERS/Jeffrey Jones

An Arctic economy in limbo

Beset by political and economic setbacks, one of the world's biggest pipeline projects is on hold, and it's unclear if the project will ever break ground.  Full Article 

Green Business